Disease · MONDO_0005258
Comparisons in its trials73
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 20 of 73
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| BUMETANIDE (S95008) vs PLACEBO: Number of Patients With Abnormalities in 12-leads Electrocardiogram (ECG) Parameters | 0 of 78 | 0 of 77 | 155 | NCT03715153 | Trial comparisons |
| GWP42003-P vs Placebo: deaths from any cause | 0 of 49 | 0 of 54 | 103 | NCT04745026 | Trial comparisons |
| GWP42003-P vs Placebo: serious adverse events | 2 of 49 | 1 of 54 | 103 | NCT04745026 | Trial comparisons |
| D-cycloserine vs Placebo: serious adverse events | 0 of 34 | 1 of 33 | 67 | NCT01086475 | Trial comparisons |
| Intranasal Oxytocin (Syntocinon) vs Placebo: deaths from any cause | 0 of 30 | 0 of 30 | 60 | NCT01908205 | Trial comparisons |
| Intranasal Oxytocin (Syntocinon) vs Placebo: serious adverse events | 0 of 30 | 0 of 30 | 60 | NCT01908205 | Trial comparisons |
| Sertraline Active Medication vs Sertraline Liquid Placebo: deaths from any cause | 0 of 32 | 0 of 26 | 58 | NCT02385799 | Trial comparisons |
| Sertraline Active Medication vs Sertraline Liquid Placebo: serious adverse events | 1 of 32 | 0 of 26 | 58 | NCT02385799 | Trial comparisons |
| Syntocinon vs Placebo: deaths from any cause | 0 of 28 | 0 of 28 | 56 | NCT01183221 | Trial comparisons |
| Syntocinon vs Placebo: serious adverse events | 0 of 28 | 0 of 28 | 56 | NCT01183221 | Trial comparisons |
| Sulforaphane vs Placebo: deaths from any cause | 0 of 32 | 0 of 23 | 55 | NCT02561481 | Trial comparisons |
| Sulforaphane vs Placebo: serious adverse events | 0 of 32 | 1 of 23 | 55 | NCT02561481 | Trial comparisons |
| Intranasal Oxytocin vs Placebo: Number of Participant Considered Overall Responders | 8 of 25 | 8 of 29 | 54 | NCT01908205 | Trial comparisons |
| Intranasal Oxytocin vs Placebo: Number of Participant Considered Social Responders | 6 of 29 | 10 of 25 | 54 | NCT01908205 | Trial comparisons |
| Intranasal Oxytocin vs Placebo: deaths from any cause | 0 of 27 | 0 of 27 | 54 | NCT02493426 | Trial comparisons |
| Intranasal Oxytocin vs Placebo: serious adverse events | 0 of 27 | 0 of 27 | 54 | NCT02493426 | Trial comparisons |
| Sulforaphane vs Placebo: deaths from any cause | 0 of 24 | 0 of 24 | 48 | NCT02909959 | Trial comparisons |
| Sulforaphane vs Placebo: serious adverse events | 0 of 24 | 0 of 24 | 48 | NCT02909959 | Trial comparisons |
| RAD001 vs Placebo: serious adverse events | 3 of 32 | 0 of 15 | 47 | NCT01289912 | Trial comparisons |
| Sapropterin vs Placebo: Clinical Global Impression -- Severity (CGI-S) Scale | 3 of 23 | 1 of 23 | 46 | NCT00850070 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0005258/comparisons